Privately held Proteus Digital Health, which is working with drugmakers including Novartis and Otsuka, said on Monday the new site would employ some 200 skilled staff and serve as a hub for the emerging digital medicine industry. The move was welcomed by Prime Minister David Cameron, who said it showed Britain’s ability to attract high-tech companies. Proteus already has European and U.S. approval for its “smart pill” technology system, in which a tiny sensor is embedded in a tablet and linked to a patch worn on the patient’s abdomen. Several teams within Britain’s state-run National Health Service plan to test the benefits of using the sensor technology in various fields, including in treating hypertension, or high blood pressure.
Comments are closed.
